These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3058041

  • 1. [Recent progress in endocrine therapy of patients with breast cancer].
    Tominaga T.
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3196-202. PubMed ID: 3058041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [New developments in hormonal therapy for breast cancer].
    Tominaga T.
    Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
    [Abstract] [Full Text] [Related]

  • 4. Management of breast cancer.
    Cohen IA, Keller JH, Abate MA.
    Clin Pharm; 1982 May; 1(6):515-29. PubMed ID: 6192963
    [Abstract] [Full Text] [Related]

  • 5. [Antihormonal treatments in breast cancer in the woman. Role of estrogen antagonists].
    Saez S.
    Bull Cancer; 1990 May; 77(9):911-6. PubMed ID: 2224163
    [Abstract] [Full Text] [Related]

  • 6. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ.
    Oncologist; 1998 May; 3(2):129-130. PubMed ID: 10388095
    [Abstract] [Full Text] [Related]

  • 7. Endocrine therapy for early breast cancer.
    Hussain SA, Williams S, Stevens A, Rea DW.
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [Abstract] [Full Text] [Related]

  • 8. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA, Palmer DH, Moon S, Rea DW.
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [Abstract] [Full Text] [Related]

  • 9. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ.
    Breast Cancer Res Treat; 1986 Dec; 7 Suppl():S23-35. PubMed ID: 3527304
    [Abstract] [Full Text] [Related]

  • 10. Endocrine management of breast cancer.
    Schneider PG, Jackisch C, Brandt B.
    Int J Fertil Menopausal Stud; 1994 Dec; 39 Suppl 2():115-27. PubMed ID: 7874188
    [Abstract] [Full Text] [Related]

  • 11. [Endocrine therapy in breast carcinoma].
    Dogliotti L, Maschietto M, Ortega C.
    Minerva Chir; 1988 Sep 30; 43(18 Suppl):63-6. PubMed ID: 3067123
    [No Abstract] [Full Text] [Related]

  • 12. [Recent development of endocrine treatment for breast cancer--new drugs and new treatment methods using tamoxifen].
    Sonoo H, Kurebayashi J.
    Gan To Kagaku Ryoho; 1993 Dec 30; 20(15):2289-99. PubMed ID: 8259841
    [Abstract] [Full Text] [Related]

  • 13. [Hormonal control of disseminated breast cancer].
    Voznyĭ EK, Meshcheriakova NG, Biakhov MIu, Vasiuta NIu.
    Sov Med; 1990 Dec 30; (6):94-7. PubMed ID: 2144368
    [No Abstract] [Full Text] [Related]

  • 14. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK, Hobbs K, Clark GM.
    Cancer Res; 1985 Feb 30; 45(2):584-90. PubMed ID: 3967234
    [Abstract] [Full Text] [Related]

  • 15. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J, Sommer A.
    J Steroid Biochem Mol Biol; 2005 Feb 30; 93(2-5):191-200. PubMed ID: 15860262
    [Abstract] [Full Text] [Related]

  • 16. [Developments in endocrine therapy for breast cancer].
    Matsui A, Ikeda T, Jinno H, Tajima G, Hohjou T, Tokura H, Mitsui Y, Asaga S, Muto T, Kitajima M.
    Gan To Kagaku Ryoho; 2002 Jul 30; 29(7):1138-45. PubMed ID: 12145993
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.
    J Clin Oncol; 2007 Feb 10; 25(5):486-92. PubMed ID: 17200148
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC, Johnston SR, Smith IE, Dowsett M.
    Clin Cancer Res; 1997 Sep 10; 3(9):1643-51. PubMed ID: 9815855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.